News

Press Releases

December 23rd, 2011

MIRADOR BIOMEDICAL Receives 510(k) Clearance for Expanded Compass™ Platform, Launches Thoracentesis and Compartment Pressure Monitoring Products

MIRADOR BIOMEDICAL Recieves 510(k) Clearance for Expanded Compass Platform, Launches Thoracentesis and Compartment Pressure Monitoring Products

July 28th, 2011

Mirador Recieves CE Mark for Compass Platform

Mirador Biomedical announced today that it has received CE Mark approval for its entire Compass™ platform as well as an ISO 13485 Quality Management System Certification. 

April 12th, 2011

Mirador Closes $1.5M Series B Round

April 12, 2011 – Mirador Biomedical announced today that it  has closed a $1.5 million Series B round of funding. The company will use the funds to expand sales of the first two Compass products and develop additional  products in the Compass platform.

February 14th, 2011

Mirador Biomedical Expands Commercialization And Appoints Steve Gappa Vice President Of Sales

Mirador Biomedical, Inc., developer and manufacturer of the Compass™ family of medical devices, today announced the addition of Steve Gappa as Vice President of Sales.

October 15th, 2010

Mirador Biomedial Announces 510(k) Clearance of the Compass™ Vascular Access and Compass™ Lumbar Puncture Devices

Mirador Biomedical, developing the innovative Compass™ family of disposable medical devices, announced FDA 510(k) clearance of its two leading products (PDF).

August 11th, 2010

Commercialization Grant Awarded to Test Mirador Biomedical’s Compass Lumbar Puncture Device

Dr. Julie Brown MD, MPH, Co-Director of Emergency Medicine Research at Seattle Children’s Research Institute, Selected for $150,000 Life Sciences Discovery Fund Award (PDF)

July 8th, 2010

Mirador Biomedical Submits 510(k) Application to FDA

Mirador Biomedical, Inc. announced today that it has filed a 510(k) application with the U.S. Food and Drug Administration requesting market clearance for the Compass™ Vascular Access (PDF)

April 16th, 2010

John Harris appointed to Board of Directors

Neurovista’s President and CEO, John Harris, appointed to Mirador Biomedical Board of Directors (PDF)

March 19th, 2010

Mirador Biomedical Closes Series A Round

Mirador Biomedical closes $1.1 million Series A Round of Funding (PDF)

October 8th, 2009

Tom Clement joins Board of Directors

Pathway Medical Co-Founder and Board Chairman, Tom Clement, joins Mirador Biomedical Board of Directors (PDF)